Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.

業績番号：2019-9

H.Xu, B.Wang, M.Ono, A.Kagita, K.Fujii, N.Sasakawa, T.Ueda, P.Gee, M.Nishikawa, M.Nomura, F.Kitaoka, T.Takahashi, K.Okita, Y.Yoshida, S.Kaneko and A.Hotta.

Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.

Cell Stem Cell 24(4); 566:578.e7; 2019.4.4

30853558

https://doi.org/10.1016/j.stem.2019.02.005